No association between Alzheimer plaques and decreased levels of cytochrome oxidase subunit mRNA, a marker of neuronal energy metabolism

被引:23
作者
Hatanpää, K [1 ]
Chandrasekaran, K [1 ]
Brady, DR [1 ]
Rapoport, SI [1 ]
机构
[1] NIA, Neurosci Lab, NIH, Bethesda, MD 20892 USA
来源
MOLECULAR BRAIN RESEARCH | 1998年 / 59卷 / 01期
关键词
amyloid beta-protein; cytochrome oxidase; immunohistochemistry; in situ hybridization; mitochondria; polyadenylated mRNA;
D O I
10.1016/S0169-328X(98)00117-X
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
It has been proposed that neuritic plaques or toxic substances diffusing from them contribute to neurodegeneration in Alzheimer disease. We examined this hypothesis by looking for evidence of decreased neuronal energy metabolism in the proximity of neuritic plaques. Levels of mitochondrial DNA-encoded mRNA for subunit III of cytochrome oxidase, a marker of neuronal energy metabolism, were determined in post mortem brain samples. Consistent with earlier results, overall cytochrome oxidase subunit III mRNA levels were decreased in Alzheimer midtemporal cortex compared with controls. However, this reduction did not correlate with plaque density. In Alzheimer brains, cytochrome oxidase subunit III mRNA levels in neurons bearing neurofibrillary tangles were lower than in tangle-free neurons. However, neuronal cell bodies in close proximity of neuritic plaques showed no decrease in cytochrome oxidase subunit III mRNA or total polyadenylated mRNA compared with more distant neurons. Cytochrome oxidase enzyme activity in neuronal processes also showed no local reduction around neuritic plaques. These results suggest that neuritic plaques do not contribute to reduced neuronal energy metabolism in Alzheimer disease. (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:13 / 21
页数:9
相关论文
共 63 条
[51]   Brain energy metabolism, cognitive function and down-regulated oxidative phosphorylation in Alzheimer disease [J].
Rapoport, SI ;
Hatanpaa, K ;
Brady, DR ;
Chandrasekaran, K .
NEURODEGENERATION, 1996, 5 (04) :473-476
[52]  
RAPOPORT SI, 1991, CEREBROVAS BRAIN MET, V3, P297
[53]   EXTENSIVE NETWORK OF PHF-TAU-RICH DYSTROPHIC NEURITES PERMEATES NEOCORTEX AND NEARLY ALL NEURITIC AND DIFFUSE AMYLOID PLAQUES IN ALZHEIMER-DISEASE [J].
SCHMIDT, ML ;
DIDARIO, AG ;
LEE, VMY ;
TROJANOWSKI, JQ .
FEBS LETTERS, 1994, 344 (01) :69-73
[54]  
SIMONIAN N, 1994, J NEUROPATHOL EXP NE, V52, P580
[55]   FUNCTIONAL ALTERATIONS IN ALZHEIMERS-DISEASE - SELECTIVE LOSS OF MITOCHONDRIAL-ENCODED CYTOCHROME-OXIDASE MESSENGER-RNA IN THE HIPPOCAMPAL-FORMATION [J].
SIMONIAN, NA ;
HYMAN, BT .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1994, 53 (05) :508-512
[56]   SOLUBLE AMYLOID BETA-PROTEIN IS A MARKER OF ALZHEIMER AMYLOID IN BRAIN BUT NOT IN CEREBROSPINAL-FLUID [J].
TABATON, M ;
NUNZI, MG ;
XUE, R ;
USIAK, M ;
AUTILIOGAMBETTI, L ;
GAMBETTI, P .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 200 (03) :1598-1603
[57]   SOME MORPHOMETRIC ASPECTS OF THE BRAIN IN SENILE DEMENTIA OF THE ALZHEIMER TYPE [J].
TERRY, RD ;
PECK, A ;
DETERESA, R ;
SCHECHTER, R ;
HOROUPIAN, DS .
ANNALS OF NEUROLOGY, 1981, 10 (02) :184-192
[58]   An agent cleaving glucose-derived protein crosslinks in vitro and in vivo [J].
Vasan, S ;
Zhang, X ;
Zhang, XN ;
Kapurniotu, A ;
Bernhagen, J ;
Teichberg, S ;
Basgen, J ;
Wagle, D ;
Shih, D ;
Terlecky, I ;
Bucala, R ;
Cerami, A ;
Egan, J ;
Ulrich, P .
NATURE, 1996, 382 (6588) :275-278
[59]  
Wharton D., 1967, METHODS ENZYMOL, V10, P245, DOI DOI 10.1016/0076-6879(67)10048-7
[60]   CHANGES IN THE VISUAL-SYSTEM OF MONOCULARLY SUTURED OR ENUCLEATED CATS DEMONSTRABLE WITH CYTOCHROME-OXIDASE HISTOCHEMISTRY [J].
WONGRILEY, M .
BRAIN RESEARCH, 1979, 171 (01) :11-28